All Stories

  1. In-silico Investigation of Ginseng Phytoconstituents as Novel Therapeutics Against MAO-A
  2. Morphine-like Novel Compounds for the Treatment of Depressive Symptoms
  3. Paradigms and Success Stories of Natural Products in Drug Discovery Against Neurodegenerative Disorders (NDDs)
  4. Pyrazoline Derivatives as Promising MAO-A Targeting Antidepressants: An Update
  5. Impact of Thread-based Microfluidic Devices in Modern Analysis: An Update on Recent Trends and Applications
  6. US-FDA Approved Drugs in 2020 and 2021: A Review
  7. Impact of Microfluidic Chip Electrophoresis in Modern Analysis: An Update on Recent Trends
  8. An Update on Recently Developed Analytical and Bio-analytical Methods for Some Anticancer Drugs
  9. Role of Vitamins in Neurodegenerative Diseases: A Review
  10. Multi-target Directed Ligands as Antidepressant Agents
  11. A Review on Post-traumatic Stress Disorder (PTSD): Symptoms, Therapies and Recent Case Studies
  12. Multi-Target-Directed Ligands as an Effective Strategy for the Treatment of Alzheimer’s Disease
  13. Analytical Methodologies for Determination of Hydroxychloroquine and its Metabolites in Pharmaceutical, Biological and Environmental Samples
  14. An Insight into Synthetic Strategies for Schiff Base Derivatives with Diverse Biological Activities
  15. A Review on Different Analytical Techniques for Determination of DNP Drugs and their Metabolites in Pharmaceutical Formulations
  16. Medicinal Perspective of Indole Derivatives: Recent Developments and Structure-Activity Relationship Studies
  17. Promising Targets in Anti-cancer Drug Development: Recent Updates
  18. Mechanisms of Tubulin Binding Ligands to Target Cancer Cells: Updates on their Therapeutic Potential and Clinical Trials
  19. A Perspective on Monoamine Oxidase Enzyme as Drug Target: Challenges and Opportunities
  20. 1,2,4-Triazole Nucleus in Anticancer Compounds
  21. Regioselective alkylation of 1,2,4-triazole using ionic liquids under microwave conditions
  22. Recent developments on the structure–activity relationship studies of MAO inhibitors and their role in different neurological disorders